Pre-Open Stock Movers

Laredo Petroleum, Inc. (NYSE: LPI) 26.8% LOWER; oil stocks lower

Avid Bioservices, Inc. (NASDAQ: CDMO) 20.5% LOWER; Recorded Third Quarter Revenue of $13.6 Million. For the third quarter of fiscal 2020, the company recorded a consolidated net loss attributable to common stockholders of $3.5 million or $0.06 per share, compared to a consolidated net loss attributable to common stockholders of $2.6 million or $0.05 per share, for the third quarter of fiscal 2019.

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) 17.5% HIGHER; coronavirus stocks higher

Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) 14.6% LOWER; Wells Fargo downgraded from Overweight to Equal Weight with a price target of $1.00.

GenMark Diagnostics, Inc. (NASDAQ: GNMK) 13.9% HIGHER; announced submission for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its ePlex SARS-CoV-2 Test. Upon issuance of an EUA, the ePlex test could be utilized by clinical laboratories for detection of SARS-CoV-2. Initial Research Use Only (RUO) tests were shipped last week to several key customers to validate the assay design using clinical samples.

Oasis Petroleum (NASDAQ: OAS) 13.9% LOWER; Cowen downgraded from Market Perform to Underperform (from $3.00).

Whiting Petroleum (NYSE: WLL) 13.3% LOWER; Cowen downgraded from Market Perform to Underperform (from $7.50).

Turtle Beach (NASDAQ: HEAR) 11.2% HIGHER; reported Q4 EPS of $0.83, $0.13 better than the analyst estimate of $0.70. Revenue for the quarter came in at $101.8 million versus the consensus estimate of $101.37 million. Turtle Beach sees Q1 2020 EPS of ($0.80)-($0.72), versus the consensus of ($0.23). Turtle Beach sees Q1 2020 revenue of $29-31 million, versus the consensus of $26.94 million.

Occidental Petroleum (NYSE: OXY) 11% LOWER; oil stocks lower again

TechnipFMC plc (NYSE: FTI) 10% LOWER; oil stocks lower again

DXC Technology (NYSE: DXC) 9.6% HIGHER; announced that it has entered into a definitive agreement to sell its U.S. State and Local Health and Human Services (State & Local HHS) business to Veritas Capital, the leading investor in government and healthcare technology businesses, for $5.0 billion in cash. The sale is the initial outcome of a process announced by DXC in November 2019 to explore strategic alternatives for three of its non-core assets.

Vivint Solar (NYSE: VSLR) 8.8% LOWER; reported Q4 EPS of ($1.02), $0.85 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $77.1 million versus the consensus estimate of $88.15 million.

Kala Pharmaceuticals, Inc. (NASDAQ: KALA) 7.2% HIGHER; announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at a public offering price of $7.89 per share, before underwriting discounts and commissions.

Marathon Oil (NYSE: MRO) 6.4% LOWER; oil stocks lower

Halliburton (NYSE: HAL) 5.9% LOWER; Tudor Pickering downgraded from Buy to Hold.

Scorpio Tankers Inc. (NYSE: STNG) 5.8% HIGHER; announced that the President of the Company, Robert Bugbee, has purchased call options on 315,100 common shares (or 3,151 call option contracts) of the Company with strike price of $15.00 and an expiration of January 2021 for the consideration of $1,963,291.

Cloudera, Inc. (NYSE: CLDR) 5.7% HIGHER; reported Q4 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $211.7 million versus the consensus estimate of $201.79 million. Cloudera, Inc. sees Q1 2021 EPS of ($0.01)-$0.01, versus the consensus of $0.03. Cloudera, Inc. sees Q1 2021 revenue of $202-207 million, versus the consensus of $205.2 million. Cloudera, Inc. sees FY2021 EPS of $0.25-$0.29, versus the consensus of ($0.01). Cloudera, Inc. sees FY2021 revenue of $860-880 million, versus the consensus of $864.7 million.

Fulgent Genetics (NASDAQ: FLGT) 4.9% LOWER; Fourth quarter revenue was $8.4 million, an increase of 48% year over year from $5.7 million in the fourth quarter of 2018. GAAP loss for the fourth quarter of 2019 was $296,000, or $0.01 per share, and non-GAAP income was $778,000, or $0.04 per share.